UY35850A - Proceso para la preparación del citalopram racemico y/o del s-ó r-citalopram mediante la separación de una mezcla de r-y s-citalopram - Google Patents

Proceso para la preparación del citalopram racemico y/o del s-ó r-citalopram mediante la separación de una mezcla de r-y s-citalopram

Info

Publication number
UY35850A
UY35850A UY0001035850A UY35850A UY35850A UY 35850 A UY35850 A UY 35850A UY 0001035850 A UY0001035850 A UY 0001035850A UY 35850 A UY35850 A UY 35850A UY 35850 A UY35850 A UY 35850A
Authority
UY
Uruguay
Prior art keywords
citalopram
racemic
preparation
mixture
separation
Prior art date
Application number
UY0001035850A
Other languages
English (en)
Inventor
Rikke Eva Humble
Troels Volsgaard Christensen
Michael Harold Rock
Nielsen Ole
Petersen Hans
Dancer Robert
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of UY35850A publication Critical patent/UY35850A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

La presente invención se refiere a un proceso para la preparación del citalopram racémico y/o del S- ó R-citalopram mediante la separación de una mezcla de R- y S-citalopram con más del 50% de uno de los enantiómeros en forma de una fracción de citalopram racémico y/o una fracción de S-citalopram ó R-citalopram que contiene bajas cantidades del otro enantiómero. La invención se refiere también a un proceso para la preparación del citalopram tanto racémico como enantioméricamente puro a partir del compuesto de R-4-[4-(dimetilamino)-1-(4-fluorfenil)-1-hidroxibutil]-3-(hidroximetil)-benzonitrilo.
UY0001035850A 2001-06-25 2014-11-21 Proceso para la preparación del citalopram racemico y/o del s-ó r-citalopram mediante la separación de una mezcla de r-y s-citalopram UY35850A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200100991 2001-06-25

Publications (1)

Publication Number Publication Date
UY35850A true UY35850A (es) 2016-06-30

Family

ID=8160584

Family Applications (2)

Application Number Title Priority Date Filing Date
UY27356A UY27356A1 (es) 2001-06-25 2002-06-25 Proceso para la peparación del citalopram racémico y/o del s-ó r-citalopram mediante la separación de una mezcla de r-y s-citalopram
UY0001035850A UY35850A (es) 2001-06-25 2014-11-21 Proceso para la preparación del citalopram racemico y/o del s-ó r-citalopram mediante la separación de una mezcla de r-y s-citalopram

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UY27356A UY27356A1 (es) 2001-06-25 2002-06-25 Proceso para la peparación del citalopram racémico y/o del s-ó r-citalopram mediante la separación de una mezcla de r-y s-citalopram

Country Status (40)

Country Link
US (1) US7112686B2 (es)
EP (1) EP1412341B1 (es)
JP (2) JP4377219B2 (es)
KR (4) KR100939945B1 (es)
CN (2) CN100429208C (es)
AR (2) AR034612A1 (es)
AT (1) ATE284395T1 (es)
BG (1) BG66372B1 (es)
BR (1) BRPI0210574B8 (es)
CA (2) CA2691149C (es)
CO (1) CO5550420A2 (es)
CZ (1) CZ305034B6 (es)
DE (1) DE60202216T2 (es)
DK (1) DK1412341T3 (es)
EA (1) EA006446B1 (es)
ES (1) ES2233834T3 (es)
HK (2) HK1068627A1 (es)
HR (1) HRP20031075B1 (es)
HU (1) HU228476B1 (es)
IL (1) IL159229A0 (es)
IS (1) IS2426B (es)
JO (1) JO2389B1 (es)
MA (1) MA26260A1 (es)
ME (2) ME00027B (es)
MX (1) MXPA03011770A (es)
MY (1) MY133471A (es)
NO (2) NO329873B1 (es)
NZ (1) NZ530104A (es)
PE (1) PE20030122A1 (es)
PL (1) PL366560A1 (es)
PT (1) PT1412341E (es)
RS (1) RS50673B (es)
SI (1) SI1412341T1 (es)
SK (1) SK287696B6 (es)
TN (1) TNSN02062A1 (es)
TW (1) TWI236473B (es)
UA (1) UA75147C2 (es)
UY (2) UY27356A1 (es)
WO (1) WO2003000672A1 (es)
ZA (1) ZA200309633B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI306846B (en) 2002-08-12 2009-03-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
EP1581483B1 (en) * 2002-12-23 2012-06-06 H. Lundbeck A/S A PROCESS FOR THE PREPARATION OF RACEMIC CITALOPRAM DIOL AND/OR i S- /i OR i R- /i CITALOPRAM DIOLS AND THE USE OF SUCH DIOLS FOR THE PREPARATION OF RACEMIC CITALOPRAM, i R- /i CITALOPRAM AND/OR i S- /i CITALOPRAM
PL378275A1 (pl) 2002-12-23 2006-03-20 H. Lundbeck A/S Bromowodorek escitalopramu i sposób jego wytwarzania
UA84859C2 (ru) * 2002-12-23 2008-12-10 Х. Луннбек А/С Способ получения свободной основы и/или кислотно-аддитивной соли рацемического циталопрамдиола и/или свободной основы и/или кислотно-аддитивной соли r- или s-циталопрамдиола
WO2004085416A1 (en) * 2003-03-24 2004-10-07 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
CN100569765C (zh) * 2003-12-19 2009-12-16 杭州民生药业集团有限公司 西酞普兰中间体晶体碱
TWI339651B (en) 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
EA200601641A1 (ru) * 2004-03-05 2006-12-29 Х. Лундбекк А/С Кристаллическая композиция, содержащая оксалат эсциталопрама
US20050196453A1 (en) 2004-03-05 2005-09-08 H. Lundbeck A/S Crystalline composition containing escitalopram
ITMI20040717A1 (it) 2004-04-09 2004-07-09 Adorkem Technology Spa Procedimento chemo-enzimatico per la preparazione dell'escitalopram
JP2006008603A (ja) * 2004-06-25 2006-01-12 Sumitomo Chemical Co Ltd 光学活性シタロプラムの製造方法、その中間体およびその製造方法
US7989645B2 (en) * 2004-08-23 2011-08-02 Sun Pharma Global Fze Process for preparation of citalopram and enantiomers
ES2285972T1 (es) 2004-08-23 2007-12-01 Sun Pharmaceutical Industries Limited Procedimiento de fabricacion de citalopram y enantiomeros.
EP1901714A2 (en) * 2005-05-20 2008-03-26 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
TWI347942B (en) * 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
US7569605B2 (en) 2005-10-14 2009-08-04 Forest Laboratories Holdings Limited Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
NZ570884A (en) 2007-09-11 2010-03-26 Lundbeck & Co As H Fractionally crystallising 4-[4-(dimethyl amino)-1-(4'-fluorophenyl)-1-hydroxybutyI]-3-(hydroxymethyl)-benzonitrile and manufacturing escitalopram therefrom
US8022232B2 (en) 2007-09-11 2011-09-20 H. Lundbeck A/S Method for manufacture of escitalopram
CN100548974C (zh) * 2007-10-11 2009-10-14 浙江大学 西酞普兰中间体的萃取分离方法
CN101560199B (zh) * 2008-04-16 2013-09-18 北京德众万全药物技术开发有限公司 一种依地普仑的制备方法
TWI381813B (zh) 2010-01-12 2013-01-11 Taiwan Paiho Ltd A Velcro assembly for a foamed article and a foamed article comprising the adhesive tape assembly

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
ATE277032T1 (de) * 1999-10-25 2004-10-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram

Also Published As

Publication number Publication date
DE60202216D1 (de) 2005-01-13
HK1132729A1 (en) 2010-03-05
HRP20031075B1 (en) 2011-12-31
HRP20031075A2 (en) 2004-04-30
NZ530104A (en) 2006-08-31
CZ305034B6 (cs) 2015-04-08
ES2233834T3 (es) 2005-06-16
IL159229A0 (en) 2004-06-01
US7112686B2 (en) 2006-09-26
PL366560A1 (en) 2005-02-07
NO335106B1 (no) 2014-09-15
RS50673B (sr) 2010-06-30
AU2002344948B2 (en) 2007-08-16
CA2691149A1 (en) 2003-01-03
CN100429208C (zh) 2008-10-29
ZA200309633B (en) 2005-02-23
MEP1508A (xx) 2010-02-10
RS101403A (en) 2007-02-05
EA006446B1 (ru) 2005-12-29
CA2450890C (en) 2011-02-15
MXPA03011770A (es) 2004-04-02
US20040259940A1 (en) 2004-12-23
ME00027B (me) 2010-02-10
HK1068627A1 (en) 2005-04-29
KR100902530B1 (ko) 2009-06-15
SI1412341T1 (en) 2005-04-30
KR100939945B1 (ko) 2010-02-04
MA26260A1 (fr) 2004-09-01
IS2426B (is) 2008-10-15
KR20080100498A (ko) 2008-11-18
UA75147C2 (en) 2006-03-15
MY133471A (en) 2007-11-30
CO5550420A2 (es) 2005-08-31
NO329873B1 (no) 2011-01-17
HUP0400293A3 (en) 2007-05-29
CN101440079B (zh) 2011-05-25
JP4377219B2 (ja) 2009-12-02
BR0210574A (pt) 2004-08-03
DE60202216T2 (de) 2005-12-08
PE20030122A1 (es) 2003-02-12
BRPI0210574B8 (pt) 2021-05-25
BG108532A (bg) 2005-04-30
HUP0400293A2 (hu) 2004-09-28
EP1412341B1 (en) 2004-12-08
CN101440079A (zh) 2009-05-27
CN1520405A (zh) 2004-08-11
NO20101420L (no) 2003-12-18
TNSN02062A1 (en) 2005-12-23
AR034612A1 (es) 2004-03-03
JP2004536093A (ja) 2004-12-02
DK1412341T3 (da) 2005-04-04
JP2009203233A (ja) 2009-09-10
TWI236473B (en) 2005-07-21
NO20035671D0 (no) 2003-12-18
UY27356A1 (es) 2003-01-31
JO2389B1 (en) 2007-06-17
AR083483A2 (es) 2013-02-27
CA2691149C (en) 2011-09-13
ATE284395T1 (de) 2004-12-15
EA200400082A1 (ru) 2004-06-24
EP1412341A1 (en) 2004-04-28
SK512004A3 (en) 2004-05-04
KR20100052550A (ko) 2010-05-19
WO2003000672A1 (en) 2003-01-03
JP5064436B2 (ja) 2012-10-31
CZ2004131A3 (cs) 2004-04-14
IS7068A (is) 2003-12-08
BR0210574B1 (pt) 2014-03-04
SK287696B6 (sk) 2011-06-06
CA2450890A1 (en) 2003-01-03
HU228476B1 (en) 2013-03-28
NO20035671L (no) 2003-12-18
KR20090031958A (ko) 2009-03-30
PT1412341E (pt) 2005-04-29
KR20040030702A (ko) 2004-04-09
BG66372B1 (bg) 2013-10-31

Similar Documents

Publication Publication Date Title
UY35850A (es) Proceso para la preparación del citalopram racemico y/o del s-ó r-citalopram mediante la separación de una mezcla de r-y s-citalopram
HK1087994A1 (en) A process for the preparation of racemic citalopram diol and/or s- or r- citalopram diols and the use of sush diols for the preparation of racemic citalopram, r-citalopram and/or s-citalopram
ATE240139T1 (de) Co-kristallisationsprozess
JP2004536093A5 (ja) Ｒ−及びｓ−シタロプラムの混合物を分離することによってラセミシタロプラム及びｓ−もしくはｒ−シタロプラムを製造する方法
AR108885A2 (es) Método para la elaboración de escitalopram
AR037795A1 (es) Metodo para la preparacion del escitalopram
DE602005017194D1 (de) Verfahren zur herstellung von carvedilol und seinen enantiomeren
DK1740571T3 (da) Fremgangsmåde til fremstilling af pyridinylmethyl-1H-benzimidazolforbindelser i enantiomerisk beriget form eller som enkelte enantiomerer
DK1733042T3 (da) Kemo-enzymatisk fremgangsmåde til fremstilling af escitalopram
BR0317629A (pt) Processo para a preparação de sal de adição de ácido e/ou base livre de diol racêmico e/ou de sal de adição de ácido e/ou base livre de r- ou s-diol, uso de sal de adição de ácido e/ou base livre de rs-diol e/ou de sal de adição de ácido e/ou base livre de s-diol e/ou de sal de adição de ácido e/ou base livre de r-diol, e, método para a preparação de sal de adição de ácido e/ou base livre de citalopram e/ou de sal de adição de ácido e/ou base livre de s-citalopram e/ou de sal de adição de ácido e/ou base livre de r-citalopram
HRP20070454A2 (en) A process for the preparation of racemic citalopram diol and/or s- or r- citalopram diols and the use of such diols for the preparation of racemic citalopram, r-citalopram and/or s-citalopram
DE602005025912D1 (de) Neues verfahren zur herstellung von 3-ä5'-(3,4-bis-hydroxymethyl-benzyloxy)-2'- ethyl-2-propyl-biphenyl-4-ylü-penta-3-ol
DK1368325T3 (da) Ny asymmetrisk fremgangsmåde til fremstilling af diarylmethylpiperazinderivater og hidtil ukendte asymmetriske diarylmethylaminer som mellemprodukter
WO2005014565A3 (en) Cis-3,5-disubstituted-dihydro-furan-2-ones and the preparation and use thereof
NO20030876L (no) Fremgangsmåte for racemisering av 1-benzyl-4-(4-fluorfenyl)-3- hydroksymetyl-1,2,3,6-tetrahydropyridin for bruk som mellomprodukt i syntese avparoxetin
WO2006127331A3 (en) Conversion process for 2,3-benzodiazepine enantiomers

Legal Events

Date Code Title Description
110 Patent granted

Effective date: 20180126

VENC Patent expired

Effective date: 20220625